This training module has been independently reviewed & certified as conforming to universally accepted Continuing Professional Development (CPD) guidelines.

This site is intended for UK healthcare professionals and other relevant decision makers only. If you are a member of the public, please click here
This training module has been independently reviewed & certified as conforming to universally accepted Continuing Professional Development (CPD) guidelines.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis via [email protected] or online through the pharmacovigilance intake (PVI) tool at www.report.novartis.com
If you have a question about the product, please contact Medical Information on 01276 698370 or by email at [email protected]